Research programme: antiviral therapy - ActoKine Therapeutics
Alternative Names: Actokine-2; AK-2Latest Information Update: 16 Jul 2016
At a glance
- Originator ActoKine Therapeutics
- Class Cytokines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in USA
- 20 May 2010 Preclinical trials in Viral infections in USA (unspecified route)